FIH To NDA In 5 Years, The Calistoga Pharmaceuticals Story
ANN ARBOR - Kicking off BioArbor?s Fall 2014 season, Carol Gallagher, past CEO of Calistoga Pharmaceuticals will present the story of the development of Zydelig and the formation and successful exit of Calistoga Pharmaceuticals on Sept. 18 at the University of Michigan North Campus Research Complex. Come hear her drug development and venture-backed company development